Zhitong Finance App News, Kanghong Pharmaceutical (002773.SZ) issued an announcement. Recently, Chengdu Kanghong Biotechnology Co., Ltd. (“Kanghong Biology” for short), a wholly-owned subsidiary of the company, received a “Drug Registration Certificate” issued by the State Drug Administration to increase indications for Compaxipu ophthalmic injections (trade name: Langmu).

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.